Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Verachtert, Anthony
NCT05162261: to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction	Completed	N/A	109	US	Tixel C, LipiFlow	Novoxel Ltd.	Meibomian Gland Dysfunction, Dry Eye Syndromes, Dry Eye	04/23	09/23
Chappell, Michael
UplighTED, NCT06307613: A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease	Recruiting	3	108	US	Efgartigimod PH20 SC, Placebo PH20 SC	argenx	Thyroid Eye Disease	02/26	10/27